acetylglucosamine has been researched along with Arrhythmias, Cardiac in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Gao, F; Jiang, T; Jin, L; Li, C; Liu, B; Qin, X; Zheng, Q | 1 |
Cao, Q; Chen, Q; Chen, S; Fu, L; Hong, K; Hu, J; Hu, L; Huang, L; Jin, J; Liu, X; Shen, Y; Wan, R; Xie, J; Xu, Z; Yan, X; Yu, J; Yu, P; Yuan, P; Zhou, Q; Zhu, W | 1 |
Roth, J; Taatjes, DJ | 1 |
Bers, DM; Copeland, RJ; Dao, K; Despa, F; Erickson, JR; Ferguson, A; Han, G; Hart, GW; Pereira, L; Ripplinger, CM; Wang, L | 1 |
4 other study(ies) available for acetylglucosamine and Arrhythmias, Cardiac
Article | Year |
---|---|
Hyper-O-GlcNAcylation impairs insulin response against reperfusion-induced myocardial injury and arrhythmias in obesity.
Topics: Acetylglucosamine; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Cell Hypoxia; Cell Line; Diazooxonorleucine; Disease Models, Animal; Glycosylation; Humans; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardial Reperfusion Injury; Myocardium; Obesity; Protein Processing, Post-Translational; Rats | 2021 |
O-GlcNAcylation of cardiac Nav1.5 contributes to the development of arrhythmias in diabetic hearts.
Topics: Acetylglucosamine; Acylation; Animals; Arrhythmias, Cardiac; Diabetes Mellitus, Experimental; HEK293 Cells; Humans; Male; NAV1.5 Voltage-Gated Sodium Channel; Rats; Rats, Sprague-Dawley | 2018 |
In focus in HCB.
Topics: Acetylglucosamine; Adipocytes; Animals; Arrhythmias, Cardiac; Biomarkers, Tumor; Gastrointestinal Tract; Genetic Diseases, X-Linked; Gigantism; Heart Defects, Congenital; Humans; Intellectual Disability; Lectins; Phenotype; Polysaccharides; Stomach Neoplasms | 2018 |
Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation.
Topics: Acetylglucosamine; Animals; Arrhythmias, Cardiac; Benzylamines; Brain; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Diabetes Complications; Diazooxonorleucine; Enzyme Activation; Glucose; Glycosylation; Humans; Hyperglycemia; Mice; Myocardium; Myocytes, Cardiac; Rats; Sarcoplasmic Reticulum; Sulfonamides | 2013 |